{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:14Z","timestamp":1792839614274,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA256977"],"award-info":[{"award-number":["R01 CA256977"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA230997"],"award-info":[{"award-number":["U01 CA230997"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA271887"],"award-info":[{"award-number":["CA271887"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["CPRIT RP200633"],"award-info":[{"award-number":["CPRIT RP200633"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cgh.2022.11.038","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T11:51:46Z","timestamp":1670845906000},"page":"2288-2297.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era"],"prefix":"10.1016","volume":"21","author":[{"given":"Anjiya","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihane N.","family":"Benhammou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasiha","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-6031","authenticated-orcid":false,"given":"George","family":"Cholankeril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.11.038_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.25662","article-title":"Differential impact of age among liver transplant candidates with and without hepatocellular carcinoma","volume":"26","author":"Cullaro","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.11.038_bib2","article-title":"Racial, ethnic, and socioeconomic disparities in treatment delay among patients with hepatocellular carcinoma in the United States","author":"Wagle","year":"2022","journal-title":"Clin Gastroenterol and Hepatol"},{"key":"10.1016\/j.cgh.2022.11.038_bib3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/hep4.1863","article-title":"Racial, ethnic, and socioeconomic disparities in curative treatment receipt and survival in hepatocellular carcinoma","volume":"6","author":"Wagle","year":"2022","journal-title":"Hepatol Comm"},{"key":"10.1016\/j.cgh.2022.11.038_bib4","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/cncr.24936","article-title":"Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma","volume":"116","author":"Yu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2022.11.038_bib5","first-page":"911173","article-title":"Racial disparities in in hospital outcomes for hepatocellular carcinoma in the United States","author":"Rajbhandari","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2022.11.038_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/ctr.12374","article-title":"Combination of racial\/ethnic and etiology\/disease-specific factors is associated with lower survival following liver transplantation in Blacks: an analysis from UNOS\/OPTN database","volume":"28","author":"Wong","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cgh.2022.11.038_bib7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2105\/AJPH.2006.102525","article-title":"Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities","volume":"98","author":"Warnecke","year":"2008","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cgh.2022.11.038_bib8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Makarova-Rusher","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2022.11.038_bib9","first-page":"1236","article-title":"Racial\/ethnic and socioeconomic disparities in use of direct-acting antivirals among Medicare beneficiaries with chronic hepatitis C, 2014-2016","volume":"25","author":"Jung","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.cgh.2022.11.038_bib10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s11606-019-04962-3","article-title":"The HCV treatment cascade: race is a factor to consider","volume":"34","author":"Balakrishnan","year":"2019","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.cgh.2022.11.038_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/cid\/ciw249","article-title":"Race and gender differences in the use of direct acting antiviral agents for hepatitis C virus","volume":"63","author":"Kanwal","year":"2016","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cgh.2022.11.038_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2017.08.020","article-title":"Improved outcomes in HCV patients following liver transplantation during the era of direct-acting antiviral agents","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.11.038_bib13","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.4254\/wjh.v7.i28.2829","article-title":"Update on hepatitis C: direct-acting antivirals","volume":"7","author":"Seifert","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2022.11.038_bib14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jamainternmed.2019.2798","article-title":"Time-series analysis of health care\u2013associated infections in a new hospital with all private rooms","volume":"179","author":"McDonald","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2022.11.038_bib15","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/hep.32067","article-title":"Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the USA","volume":"74","author":"Cholankeril","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.11.038_bib16","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2022.11.038_bib17","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/TP.0000000000001752","article-title":"Wait time of less than 6 and greater than 18 months predicts hepatocellular carcinoma recurrence after liver transplantation: proposing a wait time \u201csweet spot\u201d","volume":"101","author":"Mehta","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2022.11.038_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/lt.23398","article-title":"Development of organ-specific donor risk indices","volume":"18","author":"Akkina","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.11.038_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ajg.2010.370","article-title":"IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies","volume":"106","author":"Clark","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.11.038_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.11.038_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5604\/01.3001.0011.7385","article-title":"Direct acting antivirals improve HCV treatment initiation and adherence among underserved African Americans","volume":"17","author":"Beck","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2022.11.038_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.11.038_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/lt.21835","article-title":"The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C","volume":"15","author":"Pang","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2022.11.038_bib24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gutjnl-2015-310818","article-title":"Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk\u00a0predictor for HCC in chronic hepatitis B","volume":"65","author":"Poh","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.11.038_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.11.038_bib26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cgh.2021.12.027","article-title":"Racial and ethnic disparities in barriers to care in patients with hepatocellular carcinoma","volume":"21","author":"Schoenberger","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.11.038_bib27","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1097\/TXD.0000000000001313","article-title":"Early impact of MMaT-3 policy on liver transplant waitlist outcomes for hepatocellular carcinoma","volume":"8","author":"Shaikh","year":"2022","journal-title":"Transplant Direct"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522011302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522011302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:43:48Z","timestamp":1761543828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356522011302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1542356522011302"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.11.038","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.11.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}